Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

Big Tobacco Scores a Win Against Graphic Warning Labels on Cigarette Packs

Michael O'Riordan

December 13, 2022

News Daily News

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

Michael O'Riordan

October 07, 2022

News Daily News

FDA Plans to Slash Nicotine Levels in Cigarettes and Other Products

Michael O'Riordan

June 23, 2022

News Daily News

Postmarketing Studies of CV Devices Still Lacking in the US

Caitlin E. Cox

March 17, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

VASCADE Closure Device: FDA Database Tracks Common Complications, Deaths

Caitlin E. Cox

September 10, 2021

News Features

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Yael L. Maxwell

August 26, 2021

News Daily News

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Michael O'Riordan

March 23, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

News Industry News

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

May 02, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Industry News

FDA Approves New AGGRASTAT® Product Format

September 01, 2016

News Daily News

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

Michael O'Riordan

July 13, 2016

News Industry News

Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack

February 18, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Daily News

Sweet Surrender? Trimming Sweetness from Sugary Drinks May Cut Obesity-Related Diseases

Todd Neale

January 06, 2016

Advertisement

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Big Tobacco Scores a Win Against Graphic Warning Labels on Cigarette Packs

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

FDA Plans to Slash Nicotine Levels in Cigarettes and Other Products

Postmarketing Studies of CV Devices Still Lacking in the US

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

VASCADE Closure Device: FDA Database Tracks Common Complications, Deaths

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

TCTMD’s Top 10 Most Popular Stories for February 2019

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

FDA Approves New AGGRASTAT® Product Format

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Sweet Surrender? Trimming Sweetness from Sugary Drinks May Cut Obesity-Related Diseases

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content